News
VERV’s VERVE-102 showed an impressive 69% LDL-C reduction in its early Phase 1b data. Click here to find out why I rate VERV ...
Zacks Investment Research on MSN13h
DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock UpShares of Precision BioSciences DTIL rallied 23.8% on Tuesday after the company’s announcement that the FDA has granted Fast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback